Mercator Medical S.A. (WSE:MRC)
51.20
-0.70 (-1.35%)
Jul 22, 2026, 1:12 PM CET
Mercator Medical Ratios and Metrics
Market cap in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 22, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 481 | 351 | 467 | 442 | 525 | 1,033 | |
Market Cap Growth | 5.20% | -24.78% | 5.70% | -15.91% | -49.12% | -76.49% |
Enterprise Value | 296.3 | 171.57 | 218.32 | 118.03 | 107.52 | 1,032 |
Last Close Price | 51.20 | 37.90 | 47.80 | 41.50 | 49.35 | 97.00 |
PE Ratio | 38.85 | 12.23 | 9.00 | - | - | 2.20 |
Forward PE | - | 2.02 | 2.02 | 2.02 | 2.02 | 2.02 |
PEG Ratio | - | 0.41 | 0.41 | 0.41 | 0.41 | 0.41 |
PS Ratio | 0.84 | - | 0.86 | 0.94 | 0.97 | 0.60 |
PB Ratio | 0.53 | 0.39 | 0.50 | 0.51 | 0.52 | 902.90 |
P/TBV Ratio | 0.53 | 0.40 | 0.50 | 0.48 | 0.49 | 865.65 |
P/FCF Ratio | 32.72 | - | - | - | - | 3.17 |
P/OCF Ratio | 6.83 | - | - | - | 12.88 | 2.05 |
EV/Sales Ratio | 0.52 | - | 0.40 | 0.25 | 0.20 | 0.60 |
EV/EBITDA Ratio | 15.50 | - | 0.84 | 1.27 | 1.35 | 2.14 |
EV/EBIT Ratio | - | - | 0.92 | 1.67 | 1.99 | 2.23 |
EV/FCF Ratio | 20.15 | - | - | - | - | 3.16 |
Debt / Equity Ratio | 0.02 | 0.02 | 0.00 | 0.01 | 0.00 | 0.00 |
Debt / EBITDA Ratio | - | - | 0.02 | 0.06 | 0.04 | 0 |
Net Debt / Equity Ratio | -0.20 | -0.19 | -0.26 | -0.37 | -0.41 | -0.46 |
Net Debt / EBITDA Ratio | 0.76 | - | -0.94 | -3.46 | -5.25 | 0.00 |
Net Debt / FCF Ratio | - | - | 2.71 | 8.21 | 6.08 | 0.00 |
Asset Turnover | 0.14 | 0 | 0.54 | 0.46 | 1.00 | 2.68 |
Inventory Turnover | 1.96 | 0 | 1.90 | 2.18 | 3.70 | 11.55 |
Quick Ratio | 3.25 | 3.18 | 4.35 | 5.57 | 8.29 | 5.14 |
Current Ratio | 5.10 | 5.19 | 6.55 | 7.46 | 11.63 | 6.87 |
Return on Equity (ROE) | 0.90% | 0.00% | 5.58% | -2.44% | -37.77% | 85.20% |
Return on Assets (ROA) | -18.45% | 0.00% | 28.19% | 41.59% | 10.21% | 66.94% |
Return on Invested Capital (ROIC) | -26.22% | 0.00% | 46.49% | 75.45% | 18.72% | 173.13% |
Return on Capital Employed (ROCE) | -25.57% | 0.00% | 25.95% | 7.41% | 10.55% | 88.22% |
Earnings Yield | 2.56% | 8.18% | 11.11% | - | - | 45.52% |
FCF Yield | 3.06% | 0.00% | - | - | - | 31.59% |
Dividend Yield | 1.29% | 0.00% | 0.00% | 6.00% | 0.00% | 0.00% |
Payout Ratio | - | - | 0.00% | -121.33% | 0.00% | 0.00% |
Buyback Yield / Dilution | 1.74% | 1.80% | 2.02% | 1.91% | 3.47% | 3.88% |
Total Shareholder Return | 3.03% | 1.80% | 2.02% | 7.91% | 3.47% | 3.88% |